Cancer vaccine with minimal side effects nearing Phase 3 clinical trials
Cancer vaccine with minimal side effects nearing Phase 3 clinical trials
Melanoma cancer vaccine with minimal side effects nearing Phase 3 in clinical trials, according to experts.
![Cancer vaccine with minimal side effects nearing Phase 3 clinical trials](https://lemmy.world/pictrs/image/17618914-aee9-4e47-a986-f33f24a3799f.jpeg?format=webp&thumbnail=256)
Typically, cancer cells evade a person's immune system because it is recognized as that person's cells. Wagner developed a tumor lysate particle only (TLPO) vaccine that uses a person's tumor cells to identify particular parts that are then presented back in the body using the vaccine in a way that can stimulate their immune system to gain the ability to detect these cancer cells like an infection, allowing the immune system to fight the cancer itself.
"People used to ask me the question, 'When will there be a cure for cancer?' And I've been doing this for 60 years and I could never answer that question," Wagner said. "Until recently, until the last three or four or five years."